Celldex Therapeutics Inc
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit www.celldex.com.
Current Price
$31.34
-3.42%Celldex Therapeutics Inc (CLDX) Stock Chart
CLDX Interactive Stock Chart
Interactive stock chart for Celldex Therapeutics Inc (CLDX) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $31.34. 52-week high: $34.55. 52-week low: $18.66. 50-day moving average: $32.07. 200-day moving average: $27.07.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for CLDX. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of Celldex Therapeutics Inc's investment potential.